Cannabinoid based medicine – A practical approach for clinicians
Details & Video
Program details and agenda: Select TABS on the left (computer) or SCROLL DOWN (phone)
The program was developed by the Canadian Collaborative Research Network and was presented as three live virtual events in September/October 2020. While the live sessions were accredited for Mainpro+ and Section 1, we are pleased to make the recordings of these live sessions available to you through MD-Online. Note that the recordings have not been reviewed for accreditation.
Please select the sessions below to participate. The PROGRAM AGENDA is available here. The PROGRAM SLIDES are available from the CCRN booth in the virtual exhibit hall link below.
Thank you to our OnDemand sponsor who made it possible for us to share the recordings of this program.
The following sponsor provided support to CCRN for the OnDemand recording through an unrestricted educational grant:
Overview & Objectives
This program was developed by CCRN, a not-for-profit physician organization. The live virtual delivery sessions were held in Sep/Oct 2020 and received accreditation for both Mainpro+ and Section 1 certification. We are pleased to make recordings of these live sessions available for your review. While these recordings have not been reviewed for accreditation for OnDemand delivery, participants can earn self-learning credits through active steps outlined in the participation completion certificate.
The learning objectives for the sessions are:
• Explore current research and guidance for CBM to facilitate clinical decision-making and appropriate patient care
• Identify potential risk of CBM and mitigation strategies
• Review the role and risks of cannabinoid-based medicine in the elderly
• Implement cannabinoid-based medicine into clinical practice
• Assess the effects of cannabis on operating a vehicle and strategies to reduce risk
• Examine the use of prescription and recreational cannabis use among workers, perceptions of risk and workplace impact, and workplace consequences for their use.
• Evaluate the role of cannabinoid-based medicine for palliative and cancer associated pain
• Describe the evidence for cannabis related to the potential for opioid sparing and reduction opioid usage and rates of dependency
• Determine if cannabinoid-based medicine is helpful or harmful in a patient with a mental health disorder
|Session 1 - Clearing the confusion – Exploring the body of research and guidance documents||Mike Boivin|
|Session 1 - Drug interactions and AEs and CUD||Shelita Dattani|
|Session 1 - Geriatrics and the frail elderly||Shelita Dattani|
|Session 2 - The nuts and bolts of CBM: Prescribing, dosing, and titration, regulations, authorization and proper documentation||Alan Bell|
|Session 2 - CBM and driving||Patricia Di Ciano|
|Session 2 - Cannabis use among workers: Occupational Health considerations||Nancy Carnide|
|Session 3 - Palliative and cancer associated pain||Paul Daeninck|
|Session 3 - Opioid Sparing||Paul Oh|
|Session 3 - Cannabis and mental health: helpful or harmful?||Claude Cyr|
|Session 1 - Clearing the confusion – Exploring the body of research and guidance documents|
|Session 1 - Drug interactions and AEs and CUD|
|Session 1 - Geriatrics and the frail elderly|
|Session 2 - The nuts and bolts of CBM: Prescribing, dosing, and titration, regulations, authorization and proper documentation|
|Session 2 - CBM and driving|
Patricia Di Ciano
|Session 2 - Cannabis use among workers: Occupational Health considerations|
|Session 3 - Palliative and cancer associated pain|
|Session 3 - Opioid Sparing|
|Session 3 - Cannabis and mental health: helpful or harmful?|